AN INDEPENDENT OBSERVATIONAL STUDY OF REAL LIFE COSTS OF CARE TO MYELOMA PATIENTS IN THE ERA OF NOVEL THERAPIES
EHA Library, Jane Thompson, 266531
COMBINED ORAL ANALGESIA AND ANXIOLYSIS FOR PAIN ASSOCIATED WITH BONE MARROW ASPIRATION AND BIOPSY.
EHA Library, Claudio Cerchione, 266532
PATIENT PREFERENCES FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS OF A PATIENT SURVEY OF RAVULIZUMAB (ALXN1210) AND ECULIZUMAB
EHA Library, Ioannis Tomazos, 266533
ECONOMIC MODEL TO EVALUATE THE COST-EFFECTIVENESS OF SECOND-LINE NILOTINIB VERSUS DASATINIB FOR THE TREATMENT OF PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID LEUKEMIA (CML-CP) IN GERMANY
EHA Library, Ricardo Viana, 266534
ZINC FINGER NUCLEASE-MEDIATED DISRUPTION OF THE BCL11A ERYTHROID ENHANCER IN PLERIXAFOR MOBILIZED CD34+ CELLS RESULTS IN ENRICHED BIALLELEIC EDITING AND ALLELE-ADDITIVE INCREASES IN FETAL HEMOGLOBIN
EHA Library, Pauline RIMMELE, 266535
SURVIVAL RATES AND CAUSES OF DEATH IN ELDERLY PATIENTS WITH SICKLE CELL DISEASE
EHA Library, Valeria Maria Pinto, 266536
MORTALITY IN CHILDREN WITH SICKLE CELL DISEASE IN METROPOLITAN FRANCE FROM 2000 TO 2015
EHA Library, Valentine Brousse, 266537
SICKLE CELL DISEASE IN GERMANY IS HETEROGENEOUS AND RESULTS IN SEVERE MORBIDITY: ANALYSES FROM A NATIONAL REGISTRY
EHA Library, Andreas E. Kulozik, 266538
CEREBRAL BLOOD FLOW IN ADOLESCENTS WITH SICKLE CELL ANEMIA RECEIVING VOXELOTOR
EHA Library, Jeremie Estepp, 266539
PERIOPERATIVE CARE OF CHILDREN WITH SICKLE CELL DISEASE: A SYSTEMATIC REVIEW AND CLINICAL RECOMMENDATIONS
EHA Library, Frédérica Schyrr, 266540
CEREBRAL OXYGEN METABOLISM MEASUREMENTS WITH MRI IN ADULTS WITH SICKLE CELL DISEASE
EHA Library, Lena Vaclavu, 266541
PENICILLIN PROPHYLAXIS AND PNEUMOCOCCAL VACCINE USE IN ADULT SICKLE CELL PATIENTS: A RETROSPECTIVE ANALYSIS OF CLINICAL PRACTICE AND OUTCOMES IN OXFORD, UK
EHA Library, Ayesha Ejaz, 266542
SPECTRUM OF PARVOVIRUS B19 INFECTION IN CHILDREN WITH SICKLE CELL DISEASE: ATYPICAL PRESENTATIONS.
EHA Library, Mohamed Elshinawy, 266543
HIGH-DOSE THERAPY AND AUTOLOGOUS TRANSPLANT FOR POEMS SYNDROME: EFFECTIVE, BUT HOW TO OPTIMISE?
EHA Library, Oliver Tomkins, 266544
IMPACT OF PRETRANSPLANTATION CYTOREDUNCTION STRATEGY AND PROGNOSTIC MUTATIONS IN ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASTIC-RELATED CHANGES
EHA Library, Fengming Tien, 266545
DEFIBROTIDE TREATMENT IN ADULTS WITH SEVERE OR VERY SEVERE VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME AFTER HEMATOPOIETIC CELL TRANSPLANTATION: DEFIFRANCE STUDY INTERIM RESULTS
EHA Library, Ibrahim Yakoub-Agha, 266546
ENTEROCOCCUS-PREDOMINANT INTESTINAL MICROBIOTA INDICATES POOR PROGNOSIS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Shinsuke Kusakabe, 266547
A MACHINE-LEARNING APPROACH TO GRADE ACUTE GRAFT-VERSUS-HOST DISEASE
EHA Library, Amin Turki, 266548
SEVERE INFECTIONS IN ALLOGENEIC STEM CELL TRANSPLANT RECIPIENTS RECEIVING POST-TRANSPLANT CYCLOPHOSPHAMIDE AS GVHD PROPHYLAXIS: HAPLOIDENTICAL VS MATCHED RELATED OR UNRELATED DONOR TRANSPLANTATION
EHA Library, Anna Bosch-Vilaseca, 266549
POST-TRANSPLANT CYCLOPHOSPHAMIDE AND SIROLIMUS IN HAPLOIDENTICAL TRANSPLANT WITH PBSC GRAFTS: RESULTS IN 151 PATIENTS
EHA Library, Margherita Silani, 266550
AUTOLOGOUS STEM CELL TRANSPLANT CONDITIONING WITH CHIDAMIDE, CLADRIBINE, GEMCITABINE AND BUSULFAN AS CONSOLIDATION MAY OVERCOME POOR PROGNOSIS OF PATIENTS WITH DOUBLE EXPRESSER LYMPHOMA
EHA Library, Jie Ji, 266551
IMPACT OF ANTI-THYMOCYTE GLOBULIN DOSES IN UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PATIENTS WITH MYELOID NEOPLASM
EHA Library, Jun Yeb Nam, 266552
PERMANENT IMPAIRMENT-FREE, RELAPSE-FREE SURVIVAL: A NOVEL COMPOSITE ENDPOINT TO EVALUATE LONG-TERM SUCCESS IN ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Yoshitaka Adachi, 266553
PD-1 PATHWAY IS A KEY IMMUNOSUPPRESSIVE MECHANISM IN PATIENTS AFTER HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH TCR ΑΒ-DEPLETION.
EHA Library, Natalia Popova, 266554
DONOR UNC-93 HOMOLOG B1 GENETIC VARIATION PREDICTS SURVIVAL OUTCOMES AFTER UNRELATED BONE MARROW TRANSPLANTATION
EHA Library, Kaori Uchino, 266555
REDUCED INTENSITY CONDITIONING AND AVOIDING USE OF BROAD SPECTRUM ANTIBIOTHERAPY ACTIVE AGAINST GRAM-NEGATIVE BACTERIA MIGHT HAVE A CUMULATIVE IMPACT IN REDUCING INTESTINAL MICROBIOTA MISBALANCE.
EHA Library, Ildefonso Espigado, 266556
MULTI-CENTER, PHASE II STUDY ON HAPLOIDENTICAL BONE MARROW TRANSPLANTATION USING A RIC REGIMEN AND POST-TRANSPLANT CYCLOPHOSPHAMIDE IN PATIENTS WITH POOR PROGNOSIS LYMPHOMAS.
EHA Library, Luca Castagna, 266557
ALLOGENEIC STEM CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES FROM HLA IDENTICAL SIBLINGS OR HAPLOIDENTICAL DONORS: A COMPARISON.
EHA Library, Andrea Corbingi, 266558
DYSBIOSIS IN GUT MICROBIOTA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CAN BE DETERMINED BY THE COMBINATION OF CONDITIONING REGIMEN AND ANTIBIOTIC USAGE
EHA Library, Yasuyuki Arai, 266559
REDUCED INTENSITY CONDITIONING REGIMEN WITH ALEMTUZUMAB BASED T CELL DEPLETION ENABLES EARLY POST-TRANSPLANTATION CELLULAR INTERVENTION RESTORING GRAFT VERSUS LEUKEMIA EFFECTS IN OLDER AML PATIENTS.
EHA Library, Eva Koster, 266560
EFFECTS OF TWO DOSES OF ANTITHYMOCYTE GLOBULIN IN CONDITIONING REGIMENS FOR HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION.
EHA Library, Xiaosheng Fang, 266561
STEM CELL TRANSPLANTATION FOR MANTLE-CELL LYMPHOMA - A SINGLE CENTRE EXPERIENCE (2010-2018)
EHA Library, Telma Nascimento, 266562
PRETRANSPLANT INCREASING RATE OF LACTATE HYDROGENASE DURING TREATMENT FREE PERIOD PREDICTS TRANSPLANT OUTCOMES FOR PATIENTS WITH MYELOID HEMATOLOGICAL MALIGNANCIES NOT IN REMISSION
EHA Library, Takanobu Morishita, 266563
RESULTS OF AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) IN PATIENTS ABOVE THE AGE OF 70 ARE COMPARABLE TO THE RESULTS IN YOUNGER PATIENTS
EHA Library, Kas Mamat, 266564
T CELL EXHAUSTION PROFILE (CD4+/CD28/PER+/GRA+ CD8+/CD28/PER+/GRA+) IN STEM CELL TRANSPLANTATION, CMV RE ACTIVATIONS AND RESPIRATORY VIRUS INFECTION.CELLULAR DYNAMICS IN THE FIRST 100 DAYS POST SCT
EHA Library, Miguel Villanueva, 266565
PHASE 2 STUDY EVALUATING THE SAFETY AND EFFICACY OF ONE OR TWO DOSES OF DONOR LYMPHOCYTES DEPLETED OF HOST ALLOREACTIVE T-CELLS (ATIR101) FOLLOWING T-CELL-DEPLETED HAPLOIDENTICAL HSCT
EHA Library, Eduardo Olavarria, 266566
THE INTRAPATIENT VARIABILITY OF BLOOD LEVEL OF TACROLIMUS PREDICTS TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY
EHA Library, Ken Sagou, 266567
THE IMPACT OF PRE-TRANSPLANT CELL-FREE DNA LEVELS ON LEUKEMIA RELAPSE AND TRANSPLANT RELATED COMPLICATIONS IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
EHA Library, Zeynep Arzu Yegin, 266568
OUTCOMES FOR MELPHALAN-VELCADE BASED AUTOGRAFT IN HIGH RISK MULTIPLE MYELOMA PATIENTS: A SINGLE-CENTRE EXPERIENCE
EHA Library, David ROUTLEDGE, 266569
CHIMERISM MONITORING BY QPCR, A ROBUST PERFORMANCE FROM 0.05% TO 100%
EHA Library, Evelien Bouwmans, 266570
THE CHARLSON COMORBIDITY INDEX PREDICTS OUTCOMES FOR ELDERLY PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA AND MYELODYSPLASTIC SYNDROME
EHA Library, Sheng-Hsuan Chien, 266571
LOWER SERUM LEVELS OF ZINC AND MAGNESIUM ARE ASSOCIATED WITH WORSE ORAL CGVHD AND DYSGEUSIA IN CGVHD PATIENTS
EHA Library, Maria Radman, 266572
EXCELLENT OUTCOME OF MATCHED DONOR AND HAPLOIDENTICAL PERIPHERAL BLOOD STEM CELL TRANSPLANTATION WITH TARGETED BUSULFAN-BASED MYELOABLATIVE CONDITIONING IN PATIENTS WITH NONMALIGNANT GENETIC DISEASES.
EHA Library, Kyung Taek Hong, 266573
MONOSOMY 7 ALONE OR WITH OTHER CHROMOSOMAL ABNORMALITIES SIGNIFICANTLY AFFECT SURVIVAL OF SECONDARY AML PATIENTS TREATED WITH ALLOGENEIC- SCT
EHA Library, Mona Hassanein, 266574
HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION USING REDUCED-INTENSITY CONDITIONING FOR PEDIATRIC PATIENTS WITH FAMILIAL HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
EHA Library, Chenguang Jia, 266575
IMMUNOLOGICAL RECONSTITUTION AS A BASIS FOR THE EARLY INITIATION OF PNEUMOCOCCAL VACCINATION AFTER AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Igor Iskrov, 266576
ANALYSIS OF CENTRAL NERVOUS SYSTEM COMPLICATIONS AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, cristina insua vilas, 266577
VIABILITY OF HEMATOPOETIC STEM CELLS FOLLOWING STORAGE AT -80OC WITH 5% DIMETHYLSULFOXIDE AND HEMATOLOGIC RECOVERY IN TRANSPLANTED MYELOMA PATIENTS
EHA Library, Ivan Tonev, 266578
STEM CELL TRANSPLANTATION FOR ACQUIRED APLASTIC ANEMIA: THE ROLE OF THE CONDITIONING REGIMEN
EHA Library, SABRINA GIAMMARCO, 266579
FATTY ACID OXIDATION AND MITOCHONDRIAL OXIDATIVE PHOSPHORYLATION REGULATE T-CELL EFFECTOR FUNCTION DURING GRAFT-VERSUS-HOST DISEASE.
EHA Library, Hirofumi Nakano, 266580
MNPSEQ AS A HIGHLY SENSITIVE METHOD FOR DETECTING CHIMERISM AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Xiaodong Lyu, 266581
TREG DOWNREGULATION IS ASSOCIATED WITH INCREASE OF T CELL RESPONSES AGAINST IMMUNOGENIC ANTIGENS AND CLINICAL RESPONSES IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES AFTER DONOR LYMPHOCYTE INFUSION
EHA Library, Jochen Greiner, 266582
COMPARISON OF ALEMTUZUMAB, ANTI-THYMOCYTE GLOBULIN AND POST-TRANSPLANT CYCLOPHOSPHAMIDE FOR ACUTE GRAFT-VS-HOST DISEASE AND GRAFT-VS-LEUKEMIA EFFECT IN XENOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION.
EHA Library, Kiyomi Mashima, 266583
CHANGING CAUSES OF MORTALITY IN TDT DURING THE ERA OF ORAL CHELATION THERAPY FROM 2000 TO 2018
EHA Library, Petros Kountouris, 266584
REDUCTION OF CARDIAC OUTCOMES IN THALASSEMIA MAJOR THANKS TO A TEN-YEAR NATIONAL ITALIAN NETWORKING
EHA Library, Antonella Meloni, 266585
THE EFFICACY OF ALENDRONATE FOR THE TREATMENT OF THALASSEMIA-ASSOCIATED OSTEOPOROSIS: A RANDOMIZED CONTROLLED TRIAL
EHA Library, Pokpong Piriyakhuntorn, 266586
DATA FROM THE FRENCH REGISTRY FOR BETA-THALASSEMIA PATIENTS
EHA Library, Catherine Badens, 266587
8-YEARS' OVERALL AND EVENT FREE SURVIVAL IS SUBOPTIMAL IN A LARGE GROUP OF TRANSFUSION-DEPENDENT THALASSEMIC PATIENTS
EHA Library, Antonis KATTAMIS, 266588
RELATIONSHIP BETWEEN LIVER IRON CONCENTRATION MEASURED BY MRI T2* AND SERUM FERRITIN IN HEMOGLOBIN H DISEASE
EHA Library, Ka Lok Chan, 266589
IMPAIRMENT OF GLUTATHIONE SYSTEM AND LIPID PEROXIDATION IN PATIENTS WITH HB H DISEASE
EHA Library, Antonis KATTAMIS, 266590
IDENTIFICATION OF REFERENCE GENES IN HUMAN TUMORS FOR TUMOR EDUCATED PLATELETS (TEPS) STUDY BASED ON RNA-SEQ DATA
EHA Library, Huaichao Luo, 266591
FUNCTIONAL ACTIVITY OF PLATELETS IN THE APPLICATION OF OLIGOPEPTIDES CONTAINING РROLINE AND ARGININE
EHA Library, Marina Grigorjeva, 266592
DETECTION OF ANTIBODIES DIRECTED AGAINST DOMAIN 1 OF BETA 2 GLYCOPROTEIN I IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME 
EHA Library, Adrienne Kerényi, 266593
EXPLORING THE REAL-LIFE CLINICAL VALUE OF LOW DOSE DIRECT ANTICOAGULANTS FOR SECONDARY PREVENTION OF THROMBOEMBOLISM
EHA Library, Charalampos Kartsios, 266594
THE EFFECT OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODY UPON THROMBIN GENERATION IN NORMAL, LEIDEN HETEROZYGOUS AND FACTOR DEFICIENT PLASMAS
EHA Library, Gabor Szabo, 266595
APAC, A DUAL ANTIPLATELET AND ANTICOAGULANT - TOWARDS A LOCAL, VASCULAR TARGETING ANTITHROMBOTIC
EHA Library, Riitta Lassila, 266596
ANTITHROMBOTIC EFFECT OF SULFATED NON-ANTICOAGULANT HEPARIN WITHOUT COMPROMIZING HEMOSTASIS
EHA Library, Shaker Mousa, 266597
SULFATED NON-ANTICOAGULANT LOW MOLECULAR WEIGHT HEPARIN (S-NACH) IN COMBATING CANCER ASSOCIATED THROMBOSIS WITHOUT EFFECTS ON HEMOSTASIS
EHA Library, Shaker Mousa, 266599
DASATINIB ATTENUATES THROMBIN GENERATION AND CLOT RETRACTION OF CONVULXIN ACTIVATED HUMAN PLATELETS
EHA Library, János Kappelmayer, 266600
ANTICOAGULANT THERAPY IN THROMBOCYTOPENIC PATIENTS WITH BLOOD CANCER AND CATHETER-RELATED VTE: RESULTS FROM A DELPHI CONSENSUS ON PLATELETS COUNT BELOW 50 X 109L
EHA Library, S Siragusa, 266601
VON WILLEBRAND FACTOR DELAYS LIVER REPAIR AFTER ACETAMINOPHEN-INDUCED ACUTE LIVER INJURY IN MICE.
EHA Library, Dafna Groeneveld, 266602
SEC22B-DEPENDENT TRAFFICKING IS ESSENTIAL FOR VWF MULTIMERIZATION AND FORMATION OF ELONGATED WPBS
EHA Library, Ellie Karampini, 266603
INCIDENCE, CLINICAL FEATURES, RISK FACTORS AND OUTCOMES OF REFRACTORY ACQUIRED IMMUNE THROMBOTIC THROMBOCYTOPENIC PURPURA: A CHINESE MULTI-CENTER EXPERIENCE
EHA Library, Ruo-Yun Gui, 266604
SEPSIS INDUCED MRNA AND MIRNA LEVELS IN MEGAKARYOCYTES AND PLATELETS GENERATE ADVERSE PLATELET REACTIVITY
EHA Library, Bernadett Szilágyi, 266605
TREATMENT OF SEVERE INFECTIONS IN NEUTROPENIC PATIENTS WITH GRANULOCYTE TRANSFUSIONS: A SINGLE CENTRE EXPERIENCE IN 57 PATIENTS TREATED WITH 603 TRANSFUSIONS
EHA Library, Nika zima, 266606
COMPARISON BETWEEN COBE SPECTRA® AND SPECTRA OPTIA® APHERESIS SYSTEMS FOR HEMATOPOIETIC PROGENITOR CELLS (HPC) COLLECTION IN HEALTHY DONORS: SINGLE CENTRE EXPERIENCE
EHA Library, Beatriz Aguado Bueno, 266607
ARE NATIONAL GUIDELINES AND MANDATORY TRAINING ENOUGH TO ENSURE SAFE TRANSFUSION PRACTICE?
EHA Library, Silvia Lovato, 266608
ABO INCOMPATIBLE KIDNEY TRANSPLANTATION - ONE CENTRE EXPERIENCE
EHA Library, Marco Sampaio, 266609
PREVALENCE OF RHD VARIANTS AMONGST A PORTUGUESE BLOOD DONOR CENTRE
EHA Library, Marco Sampaio, 266610
INTRAVENOUS IRON SUPPLEMENTATION PROTOCOL FOR POST-PARTUM ANEMIA
EHA Library, Elisabetta Volpato, 266611
PROFILE OF BLOOD DONORS WITH SEROLOGIC TESTS REACTIVE IN HOSPITAL METROPOLITANO IN QUITO- ECUADOR FROM JANUARY 2016 TO DECEMBER 2018.
EHA Library, Johanna Rojas Noboa, 266612
KNOWLEDGE, ATTITUDES AND PRACTICES ON BLOOD TRANSFUSION OF MEDICAL RESIDENTS IN A TERTIARY HOSPITAL: A QUESTIONNAIRE-BASED STUDY
EHA Library, RMIN SHEILA MIRANDA, 266613
IMPROVING QUALITY IN TRANSFUSION: GAIN LIFE OPTIMIZE RESOURCES
EHA Library, Maria Yuste, 266614
DEFORMABILITY OF PACKED RED BLOOD CELLS: UNIT-TO-UNIT VARIABILITY.
EHA Library, Gregory Barshtein, 266615
INTENSIVE PLAN OF THERAPEUTIC PLASMA EXCHANGE IN PATIENT WITH EXTREME HYPERTRLIGLYCERIDEMIA DUE TO L-ASPARAGINASE IN THE CONTEXT OF SMILE PROTOCOL IN T/NK NASAL LYMPHOMA TREATMENT
EHA Library, Eduardo Sobejano, 266616
DEVELOPMENT OF DILATED CARDIOMYOPATHY AND CONGESTIVE HEART FAILURE IN A MURINE MODEL OF JAK2V617F-POSITIVE MYELOPROLIFERATIVE NEOPLASM
EHA Library, Huichun Zhan, 267057
TARGETED NEXT-GENERATION SEQUENCING IDENTIFIES NOVEL GENE VARIANTS IN JAK2V617F NEGATIVE PATIENTS WITH ERYTHROCYTOSIS AND JAK2 GGCC_46/1 HAPLOTYPE
EHA Library, Francesco ALBANO, 267061
Emerging immunotherapy in MDS and AML: The bridge between innate and
EHA Library, Arjan van de Loosdrecht, 273522
IMPACT OF CONDITIONING INTENSITY OF ALLOGENEIC TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA WITH GENOMIC EVIDENCE OF RESIDUAL DISEASE
EHA Library, Christopher Hourigan, 273253
Sequencing therapy for relapsed/refractory CLL
EHA Library, Florence Cymbalista, 274156
FIXED-DURATION VENETOCLAX PLUS OBINUTUZUMAB IMPROVES PROGRESSION-FREE SURVIVAL AND MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL AND COMORBIDITIES
EHA Library, Kirsten Fischer, 267350
TFR2-HAPLOINSUFFICIENCY ENHANCES THE BENEFICIAL EFFECT OF TMPRSS6-ANTISENSE OLIGONUCLEOTIDE TREATMENT IN BETA-THALASSEMIA MICE
EHA Library, Antonella Nai, 267349
RESULTS FROM THE RANDOMIZED PLACEBO-CONTROLLED PHASE 3 HOPE TRIAL OF VOXELOTOR IN ADULTS AND ADOLESCENTS WITH SICKLE CELL DISEASE
EHA Library, J Howard, 267348
DECIPHERING THE ROLE OF RUNX1 ISOFORMS IN THE DEVELOPMENT OF TRANSIENT ABNORMAL MYELOPOIESIS
EHA Library, Sofia Gialesaki, 267347
Impact of the gut microbiota on immunomodulation
EHA Library, Bastiaan Haak, 274164
Immune side of MDS
EHA Library, Shahram KORDASTI, 274167
There is a definite need for DOAC testing in emergency situations and elective preoperative settings!
EHA Library, Charles Marc Samama, 274216
David Grimwade Lecture: The bone marrow microenvironment dual roles: Regulation of hematopoiesis and stem cell protection
EHA Library, Tsvee Lapidot, 273521
José Carreras Lecture Award
EHA Library, Michael Hallek, 273520
Young EHA Best Abstract Awards
EHA Library, María-Victoria Mateos, 277631

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings